SCHEMBL21717831

SCHEMBL21717831

c1ccc2c(c1)cc1c3ccccc3n3c4ccc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc4c2c13

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.33
PTGES O14684 1/20 0.32
HSD17B10 Q99714 3/20 0.32
ALDH1A1 P00352 1/20 0.32
HIF1A Q16665 1/20 0.32
CYP1B1 Q16678 1/20 0.32
ALOX5 P09917 1/20 0.31
KDM4E B2RXH2 1/20 0.31
TSHR P16473 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
CASP1 P29466 1/20 0.31
GALK1 P51570 1/20 0.31
BLM P54132 1/20 0.31
CASP7 P55210 1/20 0.31
KMT2A Q03164 1/20 0.31
SAE1 Q9UBE0 1/20 0.31
UBA2 Q9UBT2 1/20 0.31
NPY5R Q15761 1/20 0.30
HPRT1 P00492 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21710664 0.94 PTGES (0.32) TSPOPTGESHSD17B10ALDH1A1HIF1A
SCHEMBL22858131 0.92 ALDH1A1 (0.41) TSPOPTGESHSD17B10ALDH1A1HIF1A
SCHEMBL22858283 0.91 TSPO (0.40) TSPOPTGESHSD17B10ALDH1A1KDM4E
SCHEMBL21717382 0.91 TSPO (0.40) TSPOPTGESHSD17B10ALDH1A1KDM4E
SCHEMBL22679275 0.89 TSPO (0.39) TSPOPTGESHSD17B10KDM4ETSHR
SCHEMBL21717832 0.89 TSPO (0.39) TSPOPTGESHSD17B10KDM4ETSHR
SCHEMBL25965152 0.86 TSPO (0.38) TSPOPTGESHSD17B10ALDH1A1KDM4E
SCHEMBL21710698 0.86 ALDH1A1 (0.41) PTGESHSD17B10ALDH1A1HIF1ACYP1B1
SCHEMBL21717407 0.85 TSPO (0.38) TSPOPTGESHSD17B10ALDH1A1HIF1A
SCHEMBL21717841 0.85 TSPO (0.38) TSPOPTGESHSD17B10ALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 TSPO 1263/4885PTGES 2858/4885HSD17B10 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.